Rabat — The signing of two cooperation agreements between Morocco and China National Biotec Group (CNBG) will enable Morocco to take part in the clinical trials of a Covid-19 vaccine, Minister of Health, Khalid Aït Taleb, said Thursday in Rabat.

This Moroccan-Chinese collaboration will allow the Kingdom to ensure that the Moroccan citizen is among the first served in terms of vaccination against the novel coronavirus, the minister told reporters following the signing ceremony via video conference, simultaneously in Rabat and Beijing, of these agreements.

Morocco will be able, probably very soon, to produce a vaccine as part of the exchange of expertise between Rabat and Beijing, he added.

The return to the normal pre-Covid-19 situation will only be possible with a vaccine, Ait Taleb pointed out, stressing that this vaccine is very promising since it has already been approved by several countries.

The minister also noted that the vaccine trials will initially involve volunteers as of next week, adding that the agreements will allow Morocco to have its own vaccine as soon as possible.

The signing of these agreements is intended to launch a first experience of clinical trials of vaccines in the Kingdom which has a substantial legal arsenal in this area, he added.

The signing ceremony of the agreement between the two parties reflects the excellent strategic relations between China and Morocco in the field of cooperation against Covid-19 which is entering a new phase, said the chargé d’Affaires of the Chinese embassy in Rabat, Jun Mao.